OxyFile #404

 

LifeTECH Scientists to Present Human IGG Abstract to Biennial 
Meeting of The International Society for Free Radical Research


TORONTO, Sept. 4 1996 /CNW/ - LifeTECH (CDN-LFTK), a biotechnology 
company with proprietary sterilization technology for blood and 
blood products, announced today that the International Society for 
Free Radical Research has accepted an abstract by LifeTECH 
scientists for presentation at the Society's VIII Biennial Meeting 
in Barcelona, Spain from October 1-5, 1996. The LifeTECH 
scientists will present data relating to the ability of LifeTECH's 
Sterizone System to destroy viruses and bacteria in Human 
Immunoglobulins.

The abstract, entitled ``Effects of Ozone on Human IgG'' (Abstract 
no. 9.29), describes the use of ozone to inactivate all viruses 
and bacteria in Human Immunoglobulins, which are made from human 
proteins extracted from blood. Human Immunoglobulins are 
transfused into tens of thousands of immune-compromised patients 
each year. The transfusion of contaminated Human Immunoglobulins 
can cause serious disease and death in these patients. LifeTECH's 
research focused on the role of free radicals, which are a by-
product of the ozone process. The authors of the abstract are 
LifeTECH's Lilian Lee, Walter J. Dermott, Karen Mason and Peter 
Lea.

In making the announcement, Walter J. Dermott, President and CEO 
said: "The worldwide implications of LifeTECH's research into the 
inactivation of viruses and bacteria continue to be recognized by 
leading medical research associations such as the International 
Society for Free Radical Research. Our research verifies that the 
Sterizone System is the most advanced technology in the world for 
sterilizing IgG, a key product for the treatment of immune-
compromised patients."

The International Society for Free Radical Research is the leading 
worldwide organization in the area of free radical research, with 
2,800 members worldwide. The primary goal of the International 
Society for Free Radical Research is to promote interest in all 
aspects of research into the reactions and properties of free 
radicals, and their physical, chemical, biological and medical 
roles.

LifeTECH Corporation is a Canadian biotechnology company dedicated 
to developing and commercializing innovative technologies to 
sterilize blood and other biological fluids. LifeTECH's 
Sterizone(TM) System is designed to inactivate viruses and 
bacteria in the global blood supply, including the HIV and 
Hepatitis viruses. LifeTECH common shares (LFTK) and warrants 
(LFTK.WT) trade on the Canadian Dealing Network.


From Canada Newswire